These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 29220113

  • 1. Effect of dexamethasone intravitreal implant on blood glucose, hypothalamic-pituitary-adrenal axis function and vascular endothelial growth factor serum levels in patients with diabetic macular oedema.
    Posch-Pertl L, Schwetz V, Michelitsch M, Rabensteiner J, Höller V, Gasser-Steiner V, Weger M, Sourij H.
    Acta Ophthalmol; 2018 Jun; 96(4):e543-e544. PubMed ID: 29220113
    [No Abstract] [Full Text] [Related]

  • 2. Dexamethasone implant for the treatment of persistent diabetic macular oedema despite long-term treatment with bevacizumab.
    Joe AW, Wickremasinghe SS, Gillies MC, Nguyen V, Lim LL, Mehta H, Fraser-Bell S.
    Clin Exp Ophthalmol; 2019 Mar; 47(2):287-289. PubMed ID: 30084193
    [No Abstract] [Full Text] [Related]

  • 3. Change in choroidal volume after dexamethasone intravitreal implant in eyes with diabetic macular oedema.
    Posch-Pertl L, Michelitsch M, Schwetz V, Gasser-Steiner V, Sourij H, Weger M.
    Acta Ophthalmol; 2019 Mar; 97(2):e320-e321. PubMed ID: 30284411
    [No Abstract] [Full Text] [Related]

  • 4. Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach.
    Giovannini A, Parravano M, Ricci F, Bandello F.
    Eur J Ophthalmol; 2019 Jan; 29(1):82-91. PubMed ID: 29882421
    [Abstract] [Full Text] [Related]

  • 5. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R, Lukic M, Boras I, Draca N, Vlasic M, Gabric N, Tomic Z.
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [Abstract] [Full Text] [Related]

  • 6. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y, Güler E, Gürağaç FB.
    Curr Eye Res; 2016 Apr; 41(1):107-13. PubMed ID: 25610946
    [Abstract] [Full Text] [Related]

  • 7. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK, Bleau L, Saunders J, Mubasher M, Stewart MW.
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [Abstract] [Full Text] [Related]

  • 8. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
    Shah SU, Harless A, Bleau L, Maturi RK.
    Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
    [Abstract] [Full Text] [Related]

  • 9. INTRAVITREAL DEXAMETHASONE IMPLANT IN PATIENTS WITH RANIBIZUMAB PERSISTENT DIABETIC MACULAR EDEMA.
    Zhioua I, Semoun O, Lalloum F, Souied EH.
    Retina; 2015 Jul; 35(7):1429-35. PubMed ID: 26102440
    [Abstract] [Full Text] [Related]

  • 10. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
    Shin YU, Hong EH, Lim HW, Kang MH, Seong M, Cho H.
    BMC Ophthalmol; 2017 Oct 03; 17(1):182. PubMed ID: 28974211
    [Abstract] [Full Text] [Related]

  • 11. Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach.
    García Layana A, Adán A, Ascaso FJ, Cabrera F, Donate J, Escobar Barranco JJ, Peralta G, Reyes García R, Rodríguez Maqueda M, Ruiz-Moreno JM, Vinagre I, MOMENTUM-D Study Group.
    Eur J Ophthalmol; 2020 Sep 03; 30(5):1042-1052. PubMed ID: 31291782
    [Abstract] [Full Text] [Related]

  • 12. Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.
    Kim M, Cho YJ, Lee CH, Lee SC.
    Eye (Lond); 2016 May 03; 30(5):718-25. PubMed ID: 26939558
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ, Kuppermann BD, Lanzetta P, Loewenstein A, Li XY, Cui H, Hashad Y, Whitcup SM, Ozurdex MEAD Study Group.
    BMC Ophthalmol; 2015 Oct 30; 15():150. PubMed ID: 26519345
    [Abstract] [Full Text] [Related]

  • 14. Letter to the Editor: Efficacy of the Intravitreal Sustained-Release Dexamethasone Implant for DME Refractory to Anti-VEGF Therapy: Meta-Analysis and Clinical Implications.
    Hennings C, Evans J, Mehta H.
    Ophthalmic Surg Lasers Imaging Retina; 2018 Sep 01; 49(9):654-655. PubMed ID: 30222798
    [No Abstract] [Full Text] [Related]

  • 15. Dexamethasone and Anti-VEGF Combination Therapy for the Treatment of Diabetic Macular Edema.
    Al-Khersan H, Hariprasad SM, Salehi-Had H.
    Ophthalmic Surg Lasers Imaging Retina; 2019 Jan 01; 50(1):4-7. PubMed ID: 30640389
    [No Abstract] [Full Text] [Related]

  • 16. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K, Ebneter A, Tuerksever C, Pruente C, Zinkernagel M.
    Ophthalmologica; 2018 Jan 01; 239(4):205-214. PubMed ID: 29402873
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.
    Esen E, Sizmaz S, Demircan N.
    Int Ophthalmol; 2017 Feb 01; 37(1):1-6. PubMed ID: 26968412
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
    Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY, Liu CC, Lou J, Whitcup SM, Ozurdex CHAMPLAIN Study Group.
    Retina; 2011 May 01; 31(5):915-23. PubMed ID: 21487341
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S, Rush R, Natarajan S, Gillies M.
    Clin Exp Ophthalmol; 2011 May 01; 39(7):673-81. PubMed ID: 22452685
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema.
    Güler E, Totan Y, Betül Güragaç F.
    Cutan Ocul Toxicol; 2017 Jun 01; 36(2):180-184. PubMed ID: 28366074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.